The Akt/mTOR and MNK/eIF4E pathways rewire the prostate cancer translatome to secrete HGF, SPP1 and BGN and recruit suppressive myeloid cells-Reference-Cited by-同舟云学术

The Akt/mTOR and MNK/eIF4E pathways rewire the prostate cancer translatome to secrete HGF, SPP1 and BGN and recruit suppressive myeloid cells

Published:2023-07-17 Issue:8 Volume:4 Page:1102-1121
ISSN:2662-1347
Container-title:Nature Cancer
language:en
Short-container-title:Nat Cancer

Author:

Brina Daniela,Ponzoni Adele,Troiani Martina,Calì Bianca,Pasquini Emiliano,Attanasio Giuseppe,Mosole Simone,Mirenda Michela,D’Ambrosio Mariantonietta,Colucci Manuel,Guccini Ilaria,Revandkar Ajinkya,Alajati Abdullah,Tebaldi Toma^ORCID,Donzel Deborah,Lauria Fabio,Parhizgari Nahjme,Valdata Aurora,Maddalena Martino,Calcinotto Arianna^ORCID,Bolis Marco^ORCID,Rinaldi Andrea,Barry Simon^ORCID,Rüschoff Jan Hendrik,Sabbadin Marianna,Sumanasuriya Semini,Crespo Mateus,Sharp Adam,Yuan Wei,Grinu Mathew,Boyle Alexandra,Miller Cynthia,Trotman Lloyd^ORCID,Delaleu Nicolas,Fassan Matteo,Moch Holger^ORCID,Viero Gabriella^ORCID,de Bono Johann^ORCID,Alimonti Andrea^ORCID

Funder

Prostate Cancer Foundation

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://www.nature.com/articles/s43018-023-00594-z.pdf

Reference86 articles.

1. Kwon, E. D. et al. Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial. Lancet Oncol. 15, 700–712 (2014).

2. de Bono, J. S. et al. Prostate carcinogenesis: inflammatory storms. Nat. Rev. Cancer 20, 455–469 (2020).

3. Feng, S. et al. Myeloid-derived suppressor cells inhibit T cell activation through nitrating LCK in mouse cancers. Proc. Natl Acad. Sci. USA 115, 10094–10099 (2018).